---
title: "Managing NAD Precursor Side Effects | HealthRX.com"
description: "A clinician-level guide to managing adverse events from NAD precursors (NMN, NR, niacin), including dosing thresholds, monitoring parameters, drug…"
url: https://healthrx.com/classes-nad-precursors/adverse-event-management
publisher: HealthRX.com
---


HealthRX.com

NMN and NR trials reported few mild side effects

Key numbers

- 250 mg/day NMN dose in a 12-week trial of 30 healthy adults; no abnormal test results and no obvious adverse effects Source: [pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/35479740/), as cited Oct 30, 2026
- 1,000 mg/day NR dose in a 2 x 6-week crossover trial of adults aged 55-79; 14 mild adverse events in 7 participants, no serious events Source: [pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/29599478/), as cited Oct 30, 2026
- 2,000 mg/day NR dose in a 12-week trial of 40 obese men; no serious adverse events and normal safety blood tests Source: [pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/29992272/), as cited Oct 30, 2026
- 3,000 mg/day NR dose for 4 weeks in a 20-person Parkinson's trial; no moderate or severe adverse events Source: [pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/38016950/), as cited Oct 30, 2026

HealthRX.com quick answer. In human trials, NMN and NR caused few adverse events and no serious ones: short NMN trials reported no severe adverse events or safety issues, and NR trials reported mild events such as nausea, flushing, leg cramps and bruising [1][2][3][4][5][6]. None of these trials describes a protocol for managing side effects. Niacin, a different NAD+ precursor, caused liver toxicity in 12 of 23 people on sustained-release tablets in a 1994 trial, versus none on immediate-release [7].

At a glance

- Drug class / [NAD precursors](https://healthrx.com/classes-nad-precursors/class-overview-monograph) (NMN, NR, niacin, nicotinamide)
- Regulatory status / NMN and NR are sold as dietary supplements; neither is FDA-approved [8]
- NMN adverse events / No severe events and no clinically relevant lab changes at 1,250 mg/day for up to 4 weeks in 31 adults [5]
- NR adverse events / 14 mild events in 7 participants at 1,000 mg/day; no serious events [3]
- Highest NR dose tested / 3,000 mg/day for 4 weeks in a 20-person Parkinson's disease trial (10 on NR), with no moderate or severe events [4]
- Long-term safety / Data beyond about 12 weeks are lacking [9]
- Niacin hepatotoxicity / Sustained-release niacin caused hepatotoxicity in 52% in one randomized trial; immediate-release caused none [7]

## What adverse events have been reported with NMN?

Human trials of NMN have been short, and the largest studied dose is 1,250 mg once daily for up to 4 weeks. In that randomized, double-blind, placebo-controlled trial of 31 healthy adults aged 20-65, there were no severe adverse events and no changes beyond normal physiological variation in hematology, biochemistry, urine, or body composition [5]. A 12-week trial of NMN 250 mg/day in 30 healthy adults found no abnormalities in physiological and laboratory tests and no obvious adverse effects [1]. A 60-day trial of 80 middle-aged adults taking 300, 600, or 900 mg/day reported no safety issues based on adverse-event, laboratory, and clinical monitoring [2]. A single-dose study in 10 healthy men tested 100, 250, and 500 mg NMN and found no significant clinical symptoms or changes in heart rate, blood pressure, oxygen saturation, or body temperature; laboratory changes, including small increases in bilirubin and decreases in creatinine, chloride, and glucose, stayed within normal ranges [10].

## What adverse events have been reported with NR?

NR trials have used higher doses than NMN trials, and the reported events are mostly mild. In a 2 x 6-week randomized, double-blind, placebo-controlled crossover trial in adults aged 55-79, NR 500 mg twice daily (1,000 mg/day) produced 14 mild adverse events in 7 participants, including nausea, flushing, leg cramps, and bruising; there were no serious events [3]. A 12-week trial of NR 1,000 mg twice daily (2,000 mg/day) in 40 obese men found no serious adverse events and normal safety blood tests [6]. In a 20-person Parkinson's disease trial (10 on NR), NR 1,500 mg twice daily (3,000 mg/day) for 4 weeks produced no moderate or severe adverse events and no significant difference in mild adverse events versus placebo; recipients had a slight initial rise in serum [homocysteine](https://healthrx.com/labs-homocysteine/what-it-measures) [4]. A 30-day trial of NR 1,000 mg/day in 30 newly diagnosed Parkinson's patients was also well tolerated [11].

One small trial reported an unexpected finding. In a 21-day crossover study of 12 men aged 70-80 taking NR 1 g/day, four men (33%) self-reported increased libido on NR and none on placebo; no clinical adverse events were reported [12].

What people on Reddit report

Reddit users describing their own experiences with NAD+ products, including oral use alongside antidepressants and injection or IV use. These are anecdotes, not controlled trial results.

Hollowpoint38 · NicotinamideRiboside

You need to run this by your doctor. If you take medication regularly for a condition that means that you need individualized advice from a professional who can look at your chart, knows your history, and knows your dosage.

Advises that anyone on regular medication should get individual advice from a prescriber before combining it with a supplement.

[Read the source discussion](https://www.reddit.com/r/NicotinamideRiboside/comments/slexu8/nad_and_effexor/)

roxrv · NicotinamideRiboside

I have done two or three intramuscular injections of NAD+ in the past couple weeks and have felt a little flat.

Reports feeling flat after a few NAD+ injections and stopped using it, doubting any benefit.

[Read the source discussion](https://www.reddit.com/r/NicotinamideRiboside/comments/1m8fr67/deleted_by_user/)

AdEmotional1386 · NicotinamideRiboside

I was doing grate suddenly I been having general weakness I stop it a week ago I don't know if is related but I am scare

Developed sudden weakness during NAD use, stopped a week before posting, and is unsure whether the two are linked.

[Read the source discussion](https://www.reddit.com/r/NicotinamideRiboside/comments/1p6ht8w/deleted_by_user/)

## What did the trials monitor?

The trials that reported safety checked adverse events, vital signs, hematology, biochemistry, urine, and body composition, depending on the study [1][2][5][6]. The reports describe monitoring and adverse-event counts, not a stepwise protocol for what to do if nausea, flushing, or a laboratory change occurs.

## What is known about niacin?

Niacin is a different case, and this trial studied people with high cholesterol, not NMN or NR. A 1994 randomized, double-blind, parallel comparison of immediate-release and sustained-release niacin in 46 adults escalated doses from 500 to 3,000 mg/day, each dose for 6 weeks [7]. Eighteen of 23 participants (78%) assigned to sustained-release niacin withdrew before completing the 3,000 mg/day dose; the most common reasons were gastrointestinal symptoms, fatigue, and increases in liver aminotransferases, often with symptoms of hepatic dysfunction. Twelve of the 23 (52%) taking sustained-release niacin developed hepatotoxic effects, while none of the 23 taking immediate-release niacin did. Nine of 23 (39%) on immediate-release niacin withdrew, most often for vasodilatory symptoms, fatigue, and acanthosis nigricans [7]. The authors concluded that sustained-release niacin is hepatotoxic, and that immediate-release niacin, although preferred in the trial, can also cause significant adverse effects [7].

## What about drug interactions and special populations?

A 2023 review of NAD+-boosting supplements identified no human drug-interaction studies of NMN or NR, including CYP, transporter, or pharmacodynamic studies [9]. Whether either supplement interacts with a prescription drug is therefore unknown. Long-term safety data beyond about 12 weeks are lacking; trials were short and small, with 12 to 140 participants [9]. Pregnancy, breastfeeding, children, and people with cancer or kidney or liver disease were not studied in these trials, so safety in these groups is unknown [9]. A theoretical concern that chronic NAD+ boosting could promote cancer has been raised, but no human data were identified [9].

Check what you know

Think you have it? Try 5 quick questions and see what the article says.

1. In the randomized NMN trial of 31 healthy adults, what severe adverse events were reported?

Question 1 of 5

Score: 0 right, 0 of 5 answered

Questions worth asking

Choose the questions you want to keep Could my current antidepressant interact with an NR or NMN supplement? Are there symptoms that mean I should stop taking NAD precursors? Has any trial checked how NMN or NR affects liver blood tests? Should my pharmacist check my medicines before I add a supplement? Is an NAD+ injection or IV safer or riskier than an oral supplement?

Frequently asked questions

What side effects did NMN trials report?

In a 4-week trial of 31 adults, NMN 1,250 mg/day caused no severe adverse events and no clinically relevant changes in hematology, biochemistry, urine, or body composition [5]. A 12-week trial of 250 mg/day in 30 adults found no abnormalities in physiological and laboratory tests [1]. A 60-day trial of 300 to 900 mg/day in 80 adults reported no safety issues [2].

What side effects did NR trials report?

At 1,000 mg/day for 6 weeks, 7 participants had 14 mild events, including nausea, flushing, leg cramps, and bruising; there were no serious events [3]. At 2,000 mg/day for 12 weeks in 40 obese men, there were no serious adverse events and safety blood tests were normal [6]. At 3,000 mg/day for 4 weeks in a 20-person Parkinson's trial (10 on NR), there were no moderate or severe adverse events [4].

Does NMN or NR interact with prescription drugs?

A 2023 review identified no human drug-interaction studies of NMN or NR, so interactions with prescription drugs are unknown [9].

What did the niacin comparison trial find?

In 46 adults, sustained-release niacin caused hepatotoxicity in 12 of 23 participants (52%), while immediate-release niacin caused none. Seventy-eight percent of the sustained-release group withdrew before the 3,000 mg/day dose, compared with 39% of the immediate-release group [7].

Reader questions

What people actually ask

Short answers drawn from the sources this article cites.

Why do I feel weird after taking NAD?

The available trial data do not explain why anyone feels unwell on NAD precursors. In NR trials, the reported mild events were nausea, flushing, leg cramps and bruising, and there were no serious events. The trials did not describe a protocol for managing these symptoms.

What to avoid when taking NAD+?

No avoidance guidance is given. Whether NMN or NR interacts with prescription drugs is unknown, because no human drug-interaction studies were identified. Pregnancy, breastfeeding, children, and people with cancer or kidney or liver disease were not studied, so safety in these groups is unknown.

References

Show all 15 references Hide references

1. Okabe K, Yaku K, Uchida Y, Fukamizu Y, Sato T, Sakurai T, et al. [Oral Administration of Nicotinamide Mononucleotide Is Safe and Efficiently Increases Blood Nicotinamide Adenine Dinucleotide Levels in Healthy Subjects](https://pubmed.ncbi.nlm.nih.gov/35479740/). Front Nutr. 2022;9:868640.
2. Yi L, Maier AB, Tao R, Lin Z, Vaidya A, Pendse S, et al. [The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial](https://pubmed.ncbi.nlm.nih.gov/36482258/). Geroscience. 2023;45(1):29-43.
3. Martens CR, Denman BA, Mazzo MR, Armstrong ML, Reisdorph N, McQueen MB, et al. [Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults](https://pubmed.ncbi.nlm.nih.gov/29599478/). Nat Commun. 2018;9(1):1286.
4. Berven H, Kverneng S, Sheard E, Søgnen M, Af Geijerstam SA, Haugarvoll K, et al. [NR-SAFE: a randomized, double-blind safety trial of high dose nicotinamide riboside in Parkinson's disease](https://pubmed.ncbi.nlm.nih.gov/38016950/). Nat Commun. 2023;14(1):7793.
5. Fukamizu Y, Uchida Y, Shigekawa A, Sato T, Kosaka H, Sakurai T. [Safety evaluation of β-nicotinamide mononucleotide oral administration in healthy adult men and women](https://pubmed.ncbi.nlm.nih.gov/36002548/). Sci Rep. 2022;12(1):14442.
6. Dollerup OL, Christensen B, Svart M, Schmidt MS, Sulek K, Ringgaard S, et al. [A randomized placebo-controlled clinical trial of nicotinamide riboside in obese men: safety, insulin-sensitivity, and lipid-mobilizing effects](https://pubmed.ncbi.nlm.nih.gov/29992272/). Am J Clin Nutr. 2018;108(2):343-353.
7. McKenney JM, Proctor JD, Harris S, Chinchili VM. [A comparison of the efficacy and toxic effects of sustained- vs immediate-release niacin in hypercholesterolemic patients](https://pubmed.ncbi.nlm.nih.gov/8309029/). JAMA. 1994;271(9):672-7.
8. [Official web page](https://www.regulations.gov/document/FDA-2023-P-0872-2754).
9. Freeberg KA, Udovich CC, Martens CR, Seals DR, Craighead DH. [Dietary Supplementation With NAD+-Boosting Compounds in Humans: Current Knowledge and Future Directions](https://pubmed.ncbi.nlm.nih.gov/37068054/). J Gerontol A Biol Sci Med Sci. 2023;78(12):2435-2448.
10. Irie J, Inagaki E, Fujita M, Nakaya H, Mitsuishi M, Yamaguchi S, et al. [Effect of oral administration of nicotinamide mononucleotide on clinical parameters and nicotinamide metabolite levels in healthy Japanese men](https://pubmed.ncbi.nlm.nih.gov/31685720/). Endocr J. 2020;67(2):153-160.
11. Brakedal B, Dölle C, Riemer F, Ma Y, Nido GS, Skeie GO, et al. [The NADPARK study: A randomized phase I trial of nicotinamide riboside supplementation in Parkinson's disease](https://pubmed.ncbi.nlm.nih.gov/35235774/). Cell Metab. 2022;34(3):396-407.e6.
12. Elhassan YS, Kluckova K, Fletcher RS, Schmidt MS, Garten A, Doig CL, et al. [Nicotinamide Riboside Augments the Aged Human Skeletal Muscle NAD+ Metabolome and Induces Transcriptomic and Anti-inflammatory Signatures](https://pubmed.ncbi.nlm.nih.gov/31412242/). Cell Rep. 2019;28(7):1717-1728.e6.
13. Reddit participants. [NAD+ and Effexor (r/NicotinamideRiboside)](https://www.reddit.com/r/NicotinamideRiboside/comments/slexu8/nad_and_effexor/). Accessed 2026-11-10.
14. Reddit participants. [\[deleted by user\] (r/NicotinamideRiboside)](https://www.reddit.com/r/NicotinamideRiboside/comments/1m8fr67/deleted_by_user/). Accessed 2026-11-10.
15. Reddit participants. [\[deleted by user\] (r/NicotinamideRiboside)](https://www.reddit.com/r/NicotinamideRiboside/comments/1p6ht8w/deleted_by_user/). Accessed 2026-11-10.

Next in this cluster

Related reading

- [nad precursors NAD precursors billing](https://healthrx.com/classes-nad-precursors/billing-and-prior-auth)
- [nad precursors NAD Precursors Class Overview Monograph](https://healthrx.com/classes-nad-precursors/class-overview-monograph)
- [nad precursors NAD precursors monitoring bundle](https://healthrx.com/classes-nad-precursors/monitoring-bundle)
- [nad precursors NAD precursors](https://healthrx.com/classes-nad-precursors/special-populations-summary)
- [nad precursors NAD precursors](https://healthrx.com/classes-nad-precursors/titration-tapering-algorithm)
- [nad precursors NAD precursors](https://healthrx.com/classes-nad-precursors/when-to-pick-which)
- [progestins vs synthetic Micronized progesterone](https://healthrx.com/classes-progestins/when-to-pick-which)
- [serms SERMs billing](https://healthrx.com/classes-selective-er-modulators/billing-and-prior-auth)
- [testosterone formulations Testosterone formulations adverse events](https://healthrx.com/classes-testosterone-formulations/adverse-event-management)
- [testosterone formulations Testosterone Formulations Billing & Prior-Auth Playbook](https://healthrx.com/classes-testosterone-formulations/billing-and-prior-auth)

![NAD precursor adverse events: pharmacist discussing side effects with a customer at a pharmacy counter](https://zwulxpn434zaufgz.public.blob.vercel-storage.com/page-images/classes-nad-precursors/adverse-event-management.webp)

A pharmacist conversation about flushing, stomach upset or lab changes helps catch problems early when taking NMN, NR or niacin. Full NAD precursors adverse events guide and sources at [healthrx.com/classes-nad-precursors](https://healthrx.com/classes-nad-precursors).

> Compounded drugs are not FDA-approved or reviewed by FDA for safety, effectiveness, or quality before marketing.
